ARCHIVES

FDA Issues Final Rules On Patient Access To Investigational Drugs

This article is from The Cancer Letter archive.

Vol. 35 No. 33 | September 11, 2009

Download PDF Visit The Full Archive

Related Articles

MGMT Gene Can Determine Disease Aggressiveness

June 24, 2011

Working Group: Restructure NCI, Improve Review Process, Encourage Independence

July 14, 1995

Deflecting Earmarks, NCI Advisors Lay Out Research Opportunities In Breast, Prostate

February 26, 1999

2,000 Breast Cancer Recurrence Biomarker Candidates Discovered

August 31, 2012

CCOP Success Acknowledged, Recompetition Plans Being Made; Cancer Control May Be Added To RFA

April 11, 1986

AACR, NCCR Advocate Five-Year Plan to Reach $10 billion Annual Cancer Budget

April 30, 1999